We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




TAP Biosystems' First Installation of ambr 48 System at Leading European Pharma

By LabMedica International staff writers
Posted on 05 Jul 2011
TAP Biosystems (Royston, UK), formerly the Automation Partnership, a leading supplier of automation and consumables for life science applications, announced it has installed a 48 bioreactor version of its advanced micro bioreactor system (ambr) system in a major European pharmaceutical company. More...
The system will assist in the prediction of antibody-expressing cell line behavior in large-scale bioreactors.

The European pharmaceutical company purchased the system after performing an on-site evaluation of ambr using their antibody-expressing CHO cell lines. The system closely duplicates bioreactor characteristics at microscale (10 mL-15 mL working volume) and was chosen after scalability of culture performance between ambr, laboratory and manufacturing scale bioreactors was demonstrated by the process development scientists.

The ambr 48 investigates the effects of 48 combinations of cell line and culture conditions. The system enables testing of up to four different temperature and stirrer speeds in a single real-time run, lowering operator time compared to similar experiments in lab scale bioreactors.

Dr. Ralph von Strandmann, TAP Biosystems' European sales manager explained: "With the increasing interest in developing biosimilars and antibody drugs in Europe, progressive pharma companies in this region recognize that our ambr technology can provide a substantial competitive advantage in reducing time to trial."

Dr. von Strandmann added: "We are pleased that this leading European pharma has chosen the ambr 48 system to help select optimum clones and culture conditions. Their confidence shows that other biopharm companies looking to shorten their therapeutic antibody development timelines can also benefit from accessing the ambr technology."

Related Links:
TAP Biosystems


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.